Martin B. Wax, MD
Dr. Wax is Chief Medical Officer and Executive Vice President of Research and Development for PanOptica, Inc. in Bernardsville, New Jersey. PanOptica is a privately owned, venture-backed ophthalmic biopharmaceutical company dedicated to the development of novel therapeutics for eye disease.
Dr. Wax is also Professor of Ophthalmology and Visual Sciences at the University of Texas Southwestern Medical School in Dallas, Texas. He has served on the Glaucoma Research Foundation Board of Directors and Scientific Advisory Board since 2003.
